Treatment recommendations in Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waidenstrom's macroglobulinemia

被引：73

作者：

Gertz, MA

Anagnostopoulos, A

Anderson, K

Branagan, AR

Coleman, M

Frankel, SR

Giralt, S

Levine, T

Munshi, N

Pestronk, A

Rajkumar, V

Treon, SP

机构：

[1] Harvard Univ, Sch Med, Waldenstroms Macroglobulinemia Program, Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Mayo Clin, Rochester, MN USA

[3] MD Anderson Canc Ctr, Houston, TX USA

[4] Cornell Univ, Weill Med Coll, New York, NY USA

[5] Greenbaum Canc Ctr, Baltimore, MD USA

[6] Univ Maryland, Baltimore, MD 21201 USA

[7] Washington Univ, Sch Med, St Louis, MO USA

来源：

SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 02期

关键词：

D O I：

10.1053/sonc.2003.50039

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：121 / 126

页数：6

共 61 条

[1] Stem cell transplantation (SCT) for Waldenstrom's macroglobulinemia (WM) [J].

Anagnostopoulos, A ;

Giralt, S .

BONE MARROW TRANSPLANTATION, 2002, 29 (12) :943-947

[2] High-dose chemotherapy - High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia [J].

Anagnostopoulos, A ;

Dimopoulos, MA ;

Aleman, A ;

Weber, D ;

Alexanian, R ;

Champlin, R ;

Giralt, S .

BONE MARROW TRANSPLANTATION, 2001, 27 (10) :1027-1029

[3]

AVNSTORP C, 1985, ACTA MED SCAND, V217, P133

[4]

BUCKLE RM, 1996, J CLIN PATHOL, V19, P55

[5]

BUSKARD NA, 1977, CAN MED ASSOC J, V117, P135

[6] Rituximab therapy in Waldenstrom's macroglobulinemia:: Preliminary evidence of clinical activity [J].

Byrd, JC ;

White, CA ;

Link, B ;

Lucas, MS ;

Velasquez, WS ;

Rosenberg, J ;

Grillo-López, AJ .

ANNALS OF ONCOLOGY, 1999, 10 (12) :1525-1527

[7] WALDENSTROMS MACROGLOBULINEMIA - LONG-TERM RESULTS WITH THE M-2 PROTOCOL [J].

CASE, DC ;

ERVIN, TJ ;

BOYD, MA ;

REDFIELD, DL .

CANCER INVESTIGATION, 1991, 9 (01) :1-7

[8] Therapeutic plasma exchange: An update from the Canadian Apheresis Group [J].

Clark, WF ;

Rock, GA ;

Buskard, N ;

Shumak, KH ;

LeBlond, P ;

Anderson, D ;

Sutton, DM .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (06) :453-462

[9] BLYD (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenstrom's macroglobulinemia [J].

Coleman, M ;

Leonard, J ;

Lyons, L ;

Pekle, K ;

Nahum, K ;

Pearse, R ;

Niesvizky, R ;

Michaeli, J .

LEUKEMIA & LYMPHOMA, 2002, 43 (09) :1777-1782

[10]

DELANNOY A, 1994, NOUV REV FR HEMATOL, V36, P317

← 1 2 3 4 5 6 7 →